PubMed HealthSearch

PubMed · 7605908

Acetylcholine esterase and peripherin mRNA level decrease in wobbler mouse.

Abstract

Homozygote wobbler mice develop motoneurone degeneration. Throughout development the expression of choline acetyltransferase, of trkC receptor and F3 adhesion molecule genes is similar in wobbler and wild-type spinal cord. Acetylcholinesterase mRNA level instead is decreased to about 50% with respect to wild-type values in one forth of P5 and P10 wobbler progeny, putative wr/wr individuals; at P21 its expression is equally highly reduced in known homozygotes and it is reduced to 35% of normal values in about one half of the progeny, putative heterozygotes. Thus, similarly to medium neurofilament gene over-expression, reduced acetylcholinesterase gene expression is an early molecular marker for the wobbler mutation before onset of the illness.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Pernas-Alonso, A E Schaffner, C T Hansen, J L Barker, U di Porzio. 1995-03-07. Acetylcholine esterase and peripherin mRNA level decrease in wobbler mouse.. https://doi.org/10.1097/00001756-199503000-00003

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Two peptides derived from the nerve growth factor precursor enhance cholinergic enzyme activities in vivo.

LIP1, a 29-amino acid (aa) peptide, and LIP2, a 38aa peptide, corresponding to sequences within the nerve growth factor (NGF) precursor that are flanked by basic amino acid processing sites, were shown to be present in the rat intestine and to induce in PC12 cells several early cellular events, such as F-actin rearrangement and tyrosine phosphorylation of the Trk protein. In this report, we provide evidence that the two propeptides can affect cholinergic enzyme activities in vivo. Intracerebroventricular injections of LIP1 or LIP2 in neonatal hypothyroid rats significantly increased choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) activities in forebrain regions with an apparent regional specificity. Moreover, antibodies against LIP1 or LIP2 injected intracerebroventricularly in neonatal rats significantly decreased ChAT and AChE in the same regions of the brain. These data suggest a physiological role for the two propeptides derived from the proNGF in the development of forebrain cholinergic neurons.

Acetylcholinesterase

Membrane-promoted unfolding of acetylcholinesterase: a possible mechanism for insertion into the lipid bilayer.

Acetylcholinesterase from Torpedo californica partially unfolds to a state with the physicochemical characteristics of a "molten globule" upon mild thermal denaturation or upon chemical modification of a single non-conserved buried cysteine residue, Cys231. The protein in this state binds tightly to liposomes. It is here shown that the rate of unfolding is greatly enhanced in the presence of unilamellar vesicles of dimyristoylphosphatidylcholine, with concomitant incorporation of the protein into the lipid bilayer. Arrhenius plots reveal that in the presence of the liposomes the energy barrier for transition from the native to the molten globule state is lowered from 145 to 47 kcal/mol. Chemical modification of Cys231 by mercuric chloride produces initially a quasinative state of Torpedo acetylcholinesterase which, at room temperature, undergoes spontaneous transition to a molten globule state with a half-life of 1-2 hr. This permitted temporal resolution of interaction of the quasi-native state with the membrane from the transition of the membrane-bound protein to the molten globule state. The data presented here suggest that either the native enzyme, or a quasi-native state with which it is in equilibrium, interacts with the liposome, which then promotes a fast transition to the membrane-bound molten globule state by lowering the energy barrier for the transition. These findings raise the possibility that the membrane itself, by lowering the energy barrier for transition to a partially unfolded state, may play an active posttranslational role in insertion and translocation of proteins in situ.

Acetylcholinesterase

A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme.

A monoclonal antibody (mAb) 25B1 directed against fetal bovine-serum acetylcholinesterase (FBS AChE) was used to examine the ability of the cholinergic enzyme to promote the assembly of amyloid-beta peptides (A beta) into Alzheimerś fibrils. This mAb binds to the peripheral anionic site of the enzyme and allosterically inhibits catalytic activity of FBS AChE. Several techniques, including thioflavine-T fluorescence, turbidity, and negative-staining at the electron microscopy level, were used to assess amyloid formation. Inhibition of amyloid formation was dependent on the molar ratio AChE:mAb 25B1, and at least 50% of the inhibition of the AChE promoting effect occurs at a molar ratio similar to that required for inhibition of the esterase activity. Our results suggest that mAb 25B1 inhibits the promotion of the amyloid fibril formation triggered by AChE by affecting the lag period of the A beta aggregation process.

Acetylcholinesterase